
Going through chemotherapy treatment was extremely difficult, and eventually I learned that sometimes, it’s OK to not be OK.

Going through chemotherapy treatment was extremely difficult, and eventually I learned that sometimes, it’s OK to not be OK.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

An expert offers three steps that patients can take to become more comfortable and confident with their ostomy after undergoing surgery for gastric cancer.

Zolbetuximab plus the chemotherapy regimen mFOLFOX6 improved progression-free survival and overall survival in certain patients with unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

My family put off future plans because of my cancer, but now I’ve decided to take risks and do what we always hoped to accomplish.

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

After undergoing a colorectal cancer surgery and getting an ostomy, patients may experience a prolapse, but it is not cause to panic, an expert says.

In the depths of chemotherapy, I found myself oscillating between being gloriously present and embarrassingly permissive.

Walking on the American Tobacco Trail has become church-like to me, as I ponder life with cancer.

My trip to the White House to advocate for myself and other patients with cancer was an empowering and memorable experience.

NC410 plus Keytruda will be studied in a phase 1b/2 trial for patients with certain solid cancers that either did not respond to or have not been treated with an immunotherapy agent.

The Food and Drug Administration approved Lytgobi for patients with previously treated advanced cholangiocarcinoma with FGFR2 gene rearrangements.

The FDA’s approval of Vegzelma was based on data that demonstrated the biosimilar elicited comparable safety and efficacy to Avastin in several studies.

While I've been deemed no evidence of disease, I'll continue to support others in my cancer wolfpack.

Cancer made me more empathetic, as well as an advocate for the HPV vaccine.

The Food and Drug Administration granted a priority review for Tukysa plus Herceptin for patients with pretreated, metastatic colon cancer.

From the delay of some health care services in the United Kingdom due to Queen Elizabeth II’s funeral to actor Ryan Reynolds broadcasting his colonoscopy — including the finding of a pre-cancerous polyp — here’s what’s happening in the cancer space this week.

Botensilimab will be evaluated in certain patients with colorectal cancer and melanoma, a type of skin cancer, in two recently launched clinical trials.

As I face the end of my life due to metastatic colorectal cancer, I’m preparing my loved ones for my death — from determining who gets my stuff to writing my eulogy and making my memorial service playlist.

None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study results.

The first patient was treated in a phase 2 trial assessing the safety and efficacy of navicixizumab, with or without chemotherapy, in colorectal, gastric, ovarian and breast cancer.

After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.

The Food and Drug Administration approved Imfinzi plus gemcitabine and cisplatin for locally advanced or metastatic biliary tract cancer.

Patients with early-stage rectal cancer may be able to forego major surgery — thus preserving their organs and quality of life — with a pre-surgical chemotherapy regimen, according to recent study results.

Researchers developed an artificial intelligence algorithm to potentially improve the prediction of colon cancer recurrence, which may help patients receive the appropriate treatment.